Tags

Type your tag names separated by a space and hit enter

Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.
Saudi Med J. 2006 Jul; 27(7):1015-8.SM

Abstract

OBJECTIVE

To evaluate the prognostic factors affecting morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome cases.

METHODS

We retrospectively evaluated, 2245 cases who delivered in the Department of Obstetrics and Gynecology, Faculty of Medicine, Cukurova University, Turkey between January and December 2002. Ninety-three cases had severe preeclampsia, 26 cases eclampsia, 19 cases HELLP syndrome, and 6 cases with eclampsia and HELLP syndrome were included in this study. The pregnancy induced hypertension cases were evaluated retrospectively for socioeconomic status, obstetrical history, biochemical parameters, and maternal complications.

RESULTS

The incidence of preeclampsia was 20.1% (453/2245), the incidence of severe preeclampsia, eclampsia, and HELLP syndrome was 6.4% (144/2245). These ratios are higher than that reported in the English literature. The complication rate was 38% in severe preeclampsia cases. Among the severe preeclampsia cases, 32 had eclampsia (22.1%), and 25 had HELLP syndrome (17.3%).

CONCLUSION

The most important biochemical marker for maternal mortality is bilirubin levels. Maternal mortality was statistically higher in cases with jaundice. Also, there was a statistically significant relation between maternal complications and liver function tests, lactate dehydrogenase levels, and low platelet levels.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Faculty of Medicine, Cukurova University, Balcali, Adana 01330, Turkey. scdemir@mail.cu.edu.trNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16830022

Citation

Demir, S Cansun, et al. "Factors That Influence Morbidity and Mortality in Severe Preeclampsia, Eclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome." Saudi Medical Journal, vol. 27, no. 7, 2006, pp. 1015-8.
Demir SC, Evruke C, Ozgunen FT, et al. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Med J. 2006;27(7):1015-8.
Demir, S. C., Evruke, C., Ozgunen, F. T., Urunsak, I. F., Candan, E., & Kadayifci, O. (2006). Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Medical Journal, 27(7), 1015-8.
Demir SC, et al. Factors That Influence Morbidity and Mortality in Severe Preeclampsia, Eclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome. Saudi Med J. 2006;27(7):1015-8. PubMed PMID: 16830022.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. AU - Demir,S Cansun, AU - Evruke,Cuneyt, AU - Ozgunen,Fatma T, AU - Urunsak,Ibrahim F, AU - Candan,Erdal, AU - Kadayifci,Oktay, PY - 2006/7/11/pubmed PY - 2007/5/18/medline PY - 2006/7/11/entrez SP - 1015 EP - 8 JF - Saudi medical journal JO - Saudi Med J VL - 27 IS - 7 N2 - OBJECTIVE: To evaluate the prognostic factors affecting morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome cases. METHODS: We retrospectively evaluated, 2245 cases who delivered in the Department of Obstetrics and Gynecology, Faculty of Medicine, Cukurova University, Turkey between January and December 2002. Ninety-three cases had severe preeclampsia, 26 cases eclampsia, 19 cases HELLP syndrome, and 6 cases with eclampsia and HELLP syndrome were included in this study. The pregnancy induced hypertension cases were evaluated retrospectively for socioeconomic status, obstetrical history, biochemical parameters, and maternal complications. RESULTS: The incidence of preeclampsia was 20.1% (453/2245), the incidence of severe preeclampsia, eclampsia, and HELLP syndrome was 6.4% (144/2245). These ratios are higher than that reported in the English literature. The complication rate was 38% in severe preeclampsia cases. Among the severe preeclampsia cases, 32 had eclampsia (22.1%), and 25 had HELLP syndrome (17.3%). CONCLUSION: The most important biochemical marker for maternal mortality is bilirubin levels. Maternal mortality was statistically higher in cases with jaundice. Also, there was a statistically significant relation between maternal complications and liver function tests, lactate dehydrogenase levels, and low platelet levels. SN - 0379-5284 UR - https://www.unboundmedicine.com/medline/citation/16830022/Factors_that_influence_morbidity_and_mortality_in_severe_preeclampsia_eclampsia_and_hemolysis_elevated_liver_enzymes_and_low_platelet_count_syndrome_ L2 - http://www.diseaseinfosearch.org/result/5920 DB - PRIME DP - Unbound Medicine ER -